Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Soliton Inc (SOLY)

Soliton Inc (SOLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 133,577
  • Shares Outstanding, K 16,973
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,750 K
  • 60-Month Beta 0.18
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 16.97

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.19
  • Number of Estimates 1
  • High Estimate -0.19
  • Low Estimate -0.19
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.56 +4.10%
on 06/26/20
15.50 -49.23%
on 06/15/20
-5.29 (-40.20%)
since 06/10/20
3-Month
7.56 +4.10%
on 06/26/20
15.50 -49.23%
on 06/15/20
-0.21 (-2.60%)
since 04/09/20
52-Week
6.64 +18.52%
on 03/20/20
21.97 -64.18%
on 07/11/19
-9.63 (-55.03%)
since 07/10/19

Most Recent Stories

More News
Soliton to Present at COVID-19 Webinar Hosted by Maxim Group on July 16th, 2020

, /PRNewswire/ -- Soliton, Inc. (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that Company CEO Chris...

SOLY : 7.87 (+1.81%)
Soliton Files 510(k) with FDA for RAP Device for the Reduction of Cellulite

, /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that it filed for 510(k)...

SOLY : 7.87 (+1.81%)
Soliton Announces Pricing of Public Offering

, /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the pricing of its underwritten...

SOLY : 7.87 (+1.81%)
Soliton Announces Proposed Public Offering of Common Stock

, /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that it intends to offer shares...

SOLY : 7.87 (+1.81%)
Soliton Reports Positive Pivotal Cellulite Clinical Trial Results

, /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that new positive data from the...

SOLY : 7.87 (+1.81%)
Soliton (SOLY) Catches Eye: Stock Jumps 5.2%

Soliton (SOLY) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

GNMK : 17.44 (-6.69%)
SOLY : 7.87 (+1.81%)
Soliton To Announce Results of Pivotal Cellulite Clinical Trial

, /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, will present the results from its pivotal cellulite...

SOLY : 7.87 (+1.81%)
Soliton Announces Pivotal Cellulite Clinical Trial Results to be Presented at AAD Virtual Meeting June 12-14

, /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the results from its pivotal...

SOLY : 7.87 (+1.81%)
Soliton Reports First Quarter 2020 Results

, /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the first...

SOLY : 7.87 (+1.81%)
Soliton Announces First Quarter 2020 Financial Results and Business Update on Thursday, May 14, 2020

, May 7, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, announced today that it will report...

SOLY : 7.87 (+1.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade SOLY with:

Business Summary

Soliton Inc. is a medical device company. Its commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos. Soliton Inc. is based in Houston, Texas.

See More

Key Turning Points

2nd Resistance Point 8.17
1st Resistance Point 8.02
Last Price 7.87
1st Support Level 7.68
2nd Support Level 7.49

See More

52-Week High 21.97
Fibonacci 61.8% 16.11
Fibonacci 50% 14.30
Fibonacci 38.2% 12.50
Last Price 7.87
52-Week Low 6.64

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar